CL
IRWD icon

Choreo LLC’s Ironwood Pharmaceuticals IRWD Stock Holding History

Choreo LLC’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-44,839
Closed -$292K – 1653
2024
Q2 		$292K Buy
+44,839
New +$317K ﹤0.01% 1108

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Choreo LLC's IRWD Position: Q3 2024 in Review

Choreo LLC sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2024, closing a stake of 44,839 shares — an estimated $292K sold.

Choreo LLC first reported a position in IRWD in Q2 2024 and held it in 1 quarter. The position peaked at $292K in Q2 2024. 221 funds tracked by Wall St. Rank hold IRWD as of Q3 2024.

  • Choreo LLC reported no remaining Ironwood Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Choreo LLC sold 44,839 Ironwood Pharmaceuticals shares in Q3 2024, an estimated $292K.
  • Choreo LLC first reported a position in Ironwood Pharmaceuticals in Q2 2024 and held it in 1 quarter.
  • Choreo LLC's Ironwood Pharmaceuticals position peaked at $292K in Q2 2024.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2024.

Based on Choreo LLC's 13F filing for Q3 2024, filed 7 Nov 2024.